We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
Brands / NEURAXPHARM / Germany
Neuraxpharm Germany

IS GERMANY’S LEADING CNS GENERIC PHARMACEUTICAL COMPANY

specialised in standard and differentiated generics and originals
Neuraxfarm Deutschland

Neuraxpharm Germany

which has a portfolio of over 100 predominantly differentiated products to serve the needs of CNS patients, has been a trusted brand for neurologists, psychiatrists, pharmacists and patients for over three decades

Neuraxpharm Germany is focused on providing their patients with high-quality, well-tolerated, easy-to-dose, affordable medicinal products, to ensure that the treatment provided is as personal and successful as possible.

Neuraxpharm Germany invests principally in the development of pharmaceutical technologies; in improving existing pharmaceutical forms and in upgrading new products. In some cases, new patient-friendly products and formulations are developed at the request of, and in close consultation with, medical specialists.

Neuraxpharm Düsseldorf
Headquartered in Düsseldorf (Germany)
neuraxpharm ARZNEIMITTEL is the Top-Selling German
specialty generic player with a focus on CNS products
CNS focus

Focus

Pipeline with mix of
  • Differentiated products
  • Standard generics
  • Niche products
  • Originals
Neuraxpharm portfolio

Portfolio

  • Strong product portfolio in specialty fields: neurology and psychiatry
  • Broad and comprehensive market portfolio with more than 100 molecules in approx. 400 pharmaceutical forms
  • #1 position in antidepressants, antipsychotics and anti-Parkinson agents


Neuraxpharm portfolio
43%
Antidepressants
28%
Antipsychotics
19%
Antiparkinson
10%
Antiepileptics
Neuraxpharm sales driver

Sales driver

  • full coverage of psychiatrists & neurologists Almost full coverage of psychiatrists & neurologists (office based) and KOLs (psychiatrists) for originals
  • partner for specialist doctors Well-established and highly respected partner for specialist doctors, pharmacists and patients
  • Advisory board with 6 KOLs
Advisory board with 6 KOLs
  • CNS foundation Social responsibility through a dedicated CNS foundation, providing support to the targeted patient/care community
    https://www.neuraxfoundation.de/
  • CNS congresses Educational service, own publications, participation in all relevant psychiatry, neurology and medical services congresses
NEURAXPHARM GERMANY market

neuraxpharm Germany
holds a 17%

market share and #1 position, sustained over the last 6 years